Free Trial

Forian (FORA) Competitors

Forian logo
$1.99 +0.06 (+2.90%)
As of 09:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FORA vs. OABI, OPRX, MXCT, PMTS, III, PESI, MIMI, TCX, RCMT, and RGP

Should you be buying Forian stock or one of its competitors? The main competitors of Forian include OmniAb (OABI), OptimizeRx (OPRX), MaxCyte (MXCT), CPI Card Group (PMTS), Information Services Group (III), Perma-Fix Environmental Services (PESI), Mint Incorporation (MIMI), Tucows (TCX), RCM Technologies (RCMT), and Resources Connection (RGP). These companies are all part of the "business services" industry.

Forian vs. Its Competitors

OmniAb (NASDAQ:OABI) and Forian (NASDAQ:FORA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

In the previous week, Forian had 7 more articles in the media than OmniAb. MarketBeat recorded 10 mentions for Forian and 3 mentions for OmniAb. Forian's average media sentiment score of 0.71 beat OmniAb's score of 0.21 indicating that Forian is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OmniAb
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Forian
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Forian has a net margin of 0.00% compared to OmniAb's net margin of -275.83%. Forian's return on equity of 0.00% beat OmniAb's return on equity.

Company Net Margins Return on Equity Return on Assets
OmniAb-275.83% -22.79% -20.18%
Forian N/A N/A N/A

OmniAb has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500. Comparatively, Forian has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.

Forian has lower revenue, but higher earnings than OmniAb. Forian is trading at a lower price-to-earnings ratio than OmniAb, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$26.39M9.44-$62.03M-$0.60-3.40
Forian$22.33M2.77-$2.81M-$0.09-22.07

72.1% of OmniAb shares are owned by institutional investors. Comparatively, 19.3% of Forian shares are owned by institutional investors. 8.6% of OmniAb shares are owned by insiders. Comparatively, 34.3% of Forian shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

OmniAb currently has a consensus price target of $6.67, indicating a potential upside of 226.80%. Forian has a consensus price target of $5.00, indicating a potential upside of 151.76%. Given OmniAb's higher possible upside, equities research analysts clearly believe OmniAb is more favorable than Forian.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OmniAb
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Forian
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Forian beats OmniAb on 9 of the 15 factors compared between the two stocks.

Get Forian News Delivered to You Automatically

Sign up to receive the latest news and ratings for FORA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FORA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FORA vs. The Competition

MetricForianHealth Information Services IndustryMedical SectorNASDAQ Exchange
Market Cap$61.97M$359.75M$5.67B$9.80B
Dividend YieldN/A5.90%4.61%4.07%
P/E Ratio-22.07365.9430.4125.56
Price / Sales2.77238.78471.98115.12
Price / CashN/A47.1438.2159.48
Price / BookN/A5.058.886.13
Net Income-$2.81M-$15.55M$3.25B$265.06M
7 Day Performance4.53%-2.43%4.72%2.94%
1 Month Performance2.90%1.76%6.73%3.32%
1 Year Performance-17.25%7.14%30.24%25.08%

Forian Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FORA
Forian
2.1711 of 5 stars
$1.99
+2.9%
$5.00
+151.8%
-21.9%$61.97M$22.33M-22.07140News Coverage
OABI
OmniAb
2.9661 of 5 stars
$1.95
+2.1%
$7.00
+259.0%
-51.3%$233.28M$26.74M-3.367
OPRX
OptimizeRx
1.2296 of 5 stars
$12.86
+2.9%
$10.81
-15.9%
+110.4%$231.19M$92.13M-15.31100High Trading Volume
MXCT
MaxCyte
3.4835 of 5 stars
$2.08
+2.0%
$7.00
+236.5%
-64.3%$217.09M$38.63M-5.2080News Coverage
Positive News
Insider Trade
PMTS
CPI Card Group
3.7986 of 5 stars
$18.69
-0.3%
$36.75
+96.6%
-42.7%$211.46M$491.43M11.751,500News Coverage
Earnings Report
Analyst Forecast
Insider Trade
Analyst Revision
III
Information Services Group
3.1809 of 5 stars
$4.29
+2.1%
$5.50
+28.2%
+55.3%$202.46M$247.59M28.601,323Gap Up
PESI
Perma-Fix Environmental Services
0.069 of 5 stars
$11.40
+7.4%
N/A+1.7%$195.78M$59.12M-9.12290
MIMI
Mint Incorporation
N/A$9.08
+9.4%
N/AN/A$188.82MN/A0.0015Gap Up
TCX
Tucows
0.9683 of 5 stars
$18.08
+9.5%
N/A-8.2%$182.55M$369.43M-1.961,000
RCMT
RCM Technologies
3.3415 of 5 stars
$23.62
+0.6%
$33.50
+41.8%
+31.9%$173.91M$278.38M13.653,140
RGP
Resources Connection
1.1515 of 5 stars
$4.65
-2.7%
$5.00
+7.5%
-53.0%$159.37M$551.33M-0.803,055

Related Companies and Tools


This page (NASDAQ:FORA) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners